I am a small-time writer/blogger who dreams big and enjoys researching and writing about biotechs and pharmaceuticals. My work experiences include food safety, water quality, pesticides, food additives, paints, plastics and pharmaceutical precursors. My focus as of late has been researching the treatment options for many cancers and prevention of their recurrence. Additional recent research has been in the stem cell field, an exciting field in its infancy but now becoming a teenager! My ongoing goal for investors is attempting to find under-the-radar or oversold pharmaceuticals or biotechs for investment potential.
Small-Cap PM and Analyst. I love to be first at bat, hitting the micro/small cap stock home-runs. I'm a portfolio builder and stock picker w/o the fluff, one who likes to avoid the crowds and the stock of the day. I'm not a stock collector (market dynamics have changed, love affairs with stocks are so yesterday)--today, a buy and hold strategy must come with an expiration date. I'm forever a thematic player; I carve out positions with an eye on tomorrow's horizon--what technology or medical break-through is going to define a sector over time. The merits of my investment selection is proven worthy only if other investors (horses) eventually follow my lead and find my watering hole.
I am a retired Chemistry and Physics teacher (and ex- Little League second baseman from the late 50's. I have been studying markets and price action for 10 years and am a positional trader who uses ETF's and individual stocks. I like to have about 5-8 positions working and while I am very familiar with bar charting with a few key indicators, I recently decided to go deeper into Point and Figure methods to reduce my workload. Hey, I'm retired.
Gotham City Capital is a private, biotech research company. Our main objective is to provide investors with low-risk, high reward biotech investments and trades. We place the utmost emphasis on small cap bios that specialize in the most promising therapies out there. In our articles, we will aim to be very specific in our strategy, whether it be a catalyst run-up trade, swing trade or long-term investment. We strive to offer consistent opportunities for investors to create high returns on our biotech picks.
With approximately six year of studies, we feel that we have an excellent balance of expertise between trading, company financing, company management and most specifically, trial data. A solid track record of successfully finding the best trades and companies has driven us to start this company. We believe in making decent size bets on the best companies.
For real time market commentary, make sure to follow Gotham City Capital on Twitter.